Dr. Reddys Labs (RDY) Misses Q1 EPS by 89c

Dr. Reddys Labs (NYSE: RDY) reported Q1 EPS of ($0.28), $0.89 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $0 versus the consensus estimate of $742.49 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Micron reports Q4 today: Why Lynx Equity sees massive upside
• FactSet (FDS) Tops Q4 EPS by 17c, Beats on Revenue; Offers FY Guidance
• S&P and Moody’s downgrade Hormel Foods following $1.05B Brakebush deal